TrialLeukemia & lymphoma2012

Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: preliminary results.

Paolo Anderlini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.